secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K/A
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001104659-24-075201
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics files financials of acquired Clade; Clade had $38.6M net loss in 2023
--------------------------------------------------------------------------------

- Clade's audited FY2023 net loss $38.6M, accumulated deficit $51.8M as of Dec 31, 2023.
- Clade had $14.2M cash at year-end 2023; going concern doubt noted for next 12 months.
- Unaudited pro forma combined financials for FY2023 filed; acquisition closed April 11, 2024.
- No deal value disclosed in this amendment; prior 8-K on April 11 announced acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465924075201/0001104659-24-075201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465924075201/tm2418216d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-075201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer